-lutamide
Non-steroid drugs that block androgen receptors.
- Drugs ending in -lutamide: 13
- Approved somewhere: 6
- With a US drug page: 6
- Stem
- -lutamide
- Class
- Non-steroid drugs that block androgen receptors
- Most common targets
- AR (8)
Approved and clinical-stage drugs in ChEMBL whose names ending in -lutamide, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Apalutamide | Approved | AR | Androgen Receptor antagonist |
| Bicalutamide | Approved | AR | Androgen Receptor antagonist |
| Darolutamide | Approved | AR | Androgen Receptor antagonist |
| Enzalutamide | Approved | AR | Androgen Receptor antagonist |
| Flutamide | Approved | AR | Androgen Receptor antagonist |
| Nilutamide | Approved | AR | Androgen Receptor antagonist |
| Pruxelutamide | Phase 3 | AR | Androgen Receptor antagonist |
| Rezvilutamide | Phase 3 | AR | Androgen Receptor antagonist |
| Gumelutamide | Phase 2 | — | — |
| Hydroxyflutamide | Phase 2 | — | — |
| Luxdegalutamide | Phase 2 | — | — |
| Bavdegalutamide | Phase 1 | — | — |
| Gridegalutamide | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO